EGFR and head and neck squamous cell carcinoma: Clinical studies have demonstrated the efficacy of EGFR inhibitors, such as monoclonal antibodies and tyrosine kinase inhibitors, in enhancing the effects of radiation and chemotherapy in HNSCC [33].